- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.23 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x ZN: ZINC ION(Non-covalent)
- 4 x PO4: PHOSPHATE ION(Non-functional Binders)
PO4.2: 12 residues within 4Å:- Chain A: N.29, G.30, G.31, N.32, E.117, H.141, H.143, W.209, H.212
- Ligands: ZN.1, ACT.3, PGO.37
7 PLIP interactions:7 interactions with chain A- Hydrogen bonds: A:N.32
- Water bridges: A:N.29, A:N.29, A:G.31
- Salt bridges: A:H.141, A:H.143, A:H.212
PO4.16: 12 residues within 4Å:- Chain B: N.29, G.30, G.31, N.32, E.117, H.141, H.143, W.209, H.212
- Ligands: PGO.9, ZN.15, ACT.17
7 PLIP interactions:7 interactions with chain B- Hydrogen bonds: B:N.32
- Water bridges: B:N.29, B:N.29, B:G.31
- Salt bridges: B:H.141, B:H.143, B:H.212
PO4.30: 12 residues within 4Å:- Chain C: N.29, G.30, G.31, N.32, E.117, H.141, H.143, W.209, H.212
- Ligands: ZN.29, ACT.31, PGO.51
7 PLIP interactions:7 interactions with chain C- Hydrogen bonds: C:N.32
- Water bridges: C:N.29, C:N.29, C:G.31
- Salt bridges: C:H.141, C:H.143, C:H.212
PO4.44: 12 residues within 4Å:- Chain D: N.29, G.30, G.31, N.32, E.117, H.141, H.143, W.209, H.212
- Ligands: PGO.23, ZN.43, ACT.45
7 PLIP interactions:7 interactions with chain D- Hydrogen bonds: D:N.32
- Water bridges: D:N.29, D:N.29, D:G.31
- Salt bridges: D:H.141, D:H.143, D:H.212
- 16 x ACT: ACETATE ION(Non-functional Binders)
ACT.3: 7 residues within 4Å:- Chain A: N.29, S.75, G.76, T.115, S.116, E.117
- Ligands: PO4.2
Ligand excluded by PLIPACT.4: 6 residues within 4Å:- Chain A: S.59, P.119, G.189, T.190, D.191
- Ligands: ACT.5
Ligand excluded by PLIPACT.5: 10 residues within 4Å:- Chain A: I.56, S.75, Y.102, V.113, P.114, T.115, S.116, L.118, P.119
- Ligands: ACT.4
Ligand excluded by PLIPACT.6: 5 residues within 4Å:- Chain A: G.76, K.77, F.78, N.81
- Chain C: D.222
Ligand excluded by PLIPACT.17: 7 residues within 4Å:- Chain B: N.29, S.75, G.76, T.115, S.116, E.117
- Ligands: PO4.16
Ligand excluded by PLIPACT.18: 6 residues within 4Å:- Chain B: S.59, P.119, G.189, T.190, D.191
- Ligands: ACT.19
Ligand excluded by PLIPACT.19: 10 residues within 4Å:- Chain B: I.56, S.75, Y.102, V.113, P.114, T.115, S.116, L.118, P.119
- Ligands: ACT.18
Ligand excluded by PLIPACT.20: 5 residues within 4Å:- Chain A: D.222
- Chain B: G.76, K.77, F.78, N.81
Ligand excluded by PLIPACT.31: 7 residues within 4Å:- Chain C: N.29, S.75, G.76, T.115, S.116, E.117
- Ligands: PO4.30
Ligand excluded by PLIPACT.32: 6 residues within 4Å:- Chain C: S.59, P.119, G.189, T.190, D.191
- Ligands: ACT.33
Ligand excluded by PLIPACT.33: 10 residues within 4Å:- Chain C: I.56, S.75, Y.102, V.113, P.114, T.115, S.116, L.118, P.119
- Ligands: ACT.32
Ligand excluded by PLIPACT.34: 5 residues within 4Å:- Chain C: G.76, K.77, F.78, N.81
- Chain D: D.222
Ligand excluded by PLIPACT.45: 7 residues within 4Å:- Chain D: N.29, S.75, G.76, T.115, S.116, E.117
- Ligands: PO4.44
Ligand excluded by PLIPACT.46: 6 residues within 4Å:- Chain D: S.59, P.119, G.189, T.190, D.191
- Ligands: ACT.47
Ligand excluded by PLIPACT.47: 10 residues within 4Å:- Chain D: I.56, S.75, Y.102, V.113, P.114, T.115, S.116, L.118, P.119
- Ligands: ACT.46
Ligand excluded by PLIPACT.48: 5 residues within 4Å:- Chain B: D.222
- Chain D: G.76, K.77, F.78, N.81
Ligand excluded by PLIP- 32 x PGO: S-1,2-PROPANEDIOL(Non-covalent)
PGO.7: 8 residues within 4Å:- Chain A: K.23, W.25, T.145, N.146, D.229, E.232, K.233, Q.236
Ligand excluded by PLIPPGO.8: 5 residues within 4Å:- Chain A: R.80, Q.83, L.84
- Chain C: D.19, L.22
Ligand excluded by PLIPPGO.9: 12 residues within 4Å:- Chain A: T.170, E.171, V.174, V.175, L.259, F.263
- Chain B: N.29, H.143, P.188, H.212
- Ligands: ZN.15, PO4.16
Ligand excluded by PLIPPGO.10: 5 residues within 4Å:- Chain A: M.244, K.248
- Chain B: V.153, L.154, Y.242
Ligand excluded by PLIPPGO.11: 6 residues within 4Å:- Chain A: P.57, L.58, S.59, Q.60, P.61, A.100
Ligand excluded by PLIPPGO.12: 7 residues within 4Å:- Chain A: Q.249, T.250, I.251, S.252, E.255
- Chain B: W.185, F.211
Ligand excluded by PLIPPGO.13: 7 residues within 4Å:- Chain A: T.158, G.181, I.182, E.200, K.203, H.204, L.268
Ligand excluded by PLIPPGO.14: 9 residues within 4Å:- Chain A: V.175, S.205, S.217, G.218, P.219, E.223, T.224, L.227
- Chain B: R.28
Ligand excluded by PLIPPGO.21: 8 residues within 4Å:- Chain B: K.23, W.25, T.145, N.146, D.229, E.232, K.233, Q.236
Ligand excluded by PLIPPGO.22: 5 residues within 4Å:- Chain A: D.19, L.22
- Chain B: R.80, Q.83, L.84
Ligand excluded by PLIPPGO.23: 12 residues within 4Å:- Chain B: T.170, E.171, V.174, V.175, L.259, F.263
- Chain D: N.29, H.143, P.188, H.212
- Ligands: ZN.43, PO4.44
Ligand excluded by PLIPPGO.24: 5 residues within 4Å:- Chain B: M.244, K.248
- Chain D: V.153, L.154, Y.242
Ligand excluded by PLIPPGO.25: 6 residues within 4Å:- Chain B: P.57, L.58, S.59, Q.60, P.61, A.100
Ligand excluded by PLIPPGO.26: 7 residues within 4Å:- Chain B: Q.249, T.250, I.251, S.252, E.255
- Chain D: W.185, F.211
Ligand excluded by PLIPPGO.27: 7 residues within 4Å:- Chain B: T.158, G.181, I.182, E.200, K.203, H.204, L.268
Ligand excluded by PLIPPGO.28: 9 residues within 4Å:- Chain B: V.175, S.205, S.217, G.218, P.219, E.223, T.224, L.227
- Chain D: R.28
Ligand excluded by PLIPPGO.35: 8 residues within 4Å:- Chain C: K.23, W.25, T.145, N.146, D.229, E.232, K.233, Q.236
Ligand excluded by PLIPPGO.36: 5 residues within 4Å:- Chain C: R.80, Q.83, L.84
- Chain D: D.19, L.22
Ligand excluded by PLIPPGO.37: 12 residues within 4Å:- Chain A: N.29, H.143, P.188, H.212
- Chain C: T.170, E.171, V.174, V.175, L.259, F.263
- Ligands: ZN.1, PO4.2
Ligand excluded by PLIPPGO.38: 5 residues within 4Å:- Chain A: V.153, L.154, Y.242
- Chain C: M.244, K.248
Ligand excluded by PLIPPGO.39: 6 residues within 4Å:- Chain C: P.57, L.58, S.59, Q.60, P.61, A.100
Ligand excluded by PLIPPGO.40: 7 residues within 4Å:- Chain A: W.185, F.211
- Chain C: Q.249, T.250, I.251, S.252, E.255
Ligand excluded by PLIPPGO.41: 7 residues within 4Å:- Chain C: T.158, G.181, I.182, E.200, K.203, H.204, L.268
Ligand excluded by PLIPPGO.42: 9 residues within 4Å:- Chain A: R.28
- Chain C: V.175, S.205, S.217, G.218, P.219, E.223, T.224, L.227
Ligand excluded by PLIPPGO.49: 8 residues within 4Å:- Chain D: K.23, W.25, T.145, N.146, D.229, E.232, K.233, Q.236
Ligand excluded by PLIPPGO.50: 5 residues within 4Å:- Chain B: D.19, L.22
- Chain D: R.80, Q.83, L.84
Ligand excluded by PLIPPGO.51: 12 residues within 4Å:- Chain C: N.29, H.143, P.188, H.212
- Chain D: T.170, E.171, V.174, V.175, L.259, F.263
- Ligands: ZN.29, PO4.30
Ligand excluded by PLIPPGO.52: 5 residues within 4Å:- Chain C: V.153, L.154, Y.242
- Chain D: M.244, K.248
Ligand excluded by PLIPPGO.53: 6 residues within 4Å:- Chain D: P.57, L.58, S.59, Q.60, P.61, A.100
Ligand excluded by PLIPPGO.54: 7 residues within 4Å:- Chain C: W.185, F.211
- Chain D: Q.249, T.250, I.251, S.252, E.255
Ligand excluded by PLIPPGO.55: 7 residues within 4Å:- Chain D: T.158, G.181, I.182, E.200, K.203, H.204, L.268
Ligand excluded by PLIPPGO.56: 9 residues within 4Å:- Chain C: R.28
- Chain D: V.175, S.205, S.217, G.218, P.219, E.223, T.224, L.227
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Grueninger, D. et al., Designed Protein-Protein Association. Science (2008)
- Release Date
- 2008-01-15
- Peptides
- RHAMNULOSE-1-PHOSPHATE ALDOLASE: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.23 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x ZN: ZINC ION(Non-covalent)
- 4 x PO4: PHOSPHATE ION(Non-functional Binders)
- 16 x ACT: ACETATE ION(Non-functional Binders)
- 32 x PGO: S-1,2-PROPANEDIOL(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Grueninger, D. et al., Designed Protein-Protein Association. Science (2008)
- Release Date
- 2008-01-15
- Peptides
- RHAMNULOSE-1-PHOSPHATE ALDOLASE: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A